Genmed Holding Corp. (OTCBB: GENM) has announced that in preparation for its initial shipments to its distributors the Company has made an addition to its management team. The Company hired Dr. Frank A. Bodaan as its dedicated sales manager for the European market.
"The addition of Dr. Bodaan comes at a critical time in Genmed's development as our products are being prepared to be shipped to our distribution partners. Dr. Bodaan's role is to provide marketing and sales support to our distributor network as well as to identify and implement strategic initiatives which help build Genmed's brand awareness and revenue growth," said Erwin Bouwens, CEO of Genmed.
Dr. Bodaan earned his PhD in Business Economics at Erasmus University Rotterdam and has extensive experience in business-to-business marketing and sales. Bouwens said further, "The Company made several announcements earlier this year regarding the expansion of our distribution network and the hiring of Dr. Bodaan is a direct response to furthering those relationships and developing new ones. He has already begun his efforts and we are already seeing very positive results."
About Genmed Holding Corp.
Genmed Holding Corp. is a fully reporting publicly traded company that trades on the OTC under the symbol GENM. It is a United States- and Dutch-based company focusing on the delivery of low-cost generic pharmaceutical drugs directly to distribution channels throughout the world. The Company began its generic drug business in 2008 and today operates primarily through its 100% owned subsidiary Genmed B.V., which is registered in the Netherlands. The Company is led by an experienced management team and board who have considerable and highly relevant experience in product development, registration, sales, marketing, distribution, operations, and financial administration.
For additional information, go to the Website: www.genmed.nl
This press release contains certain "forward-looking statements" within the meaning of federal securities laws, including the use of the words "expect," "anticipate," "estimate," "project," "forecast," "outlook," "target," "objective," "plan," "goal," "pursue," "on track," and similar expressions. Although the Company believes that the statements were reasonable when made, these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the company to be different from those expressed or implied. The Company assumes no obligation and does not intend to update these forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without limitation: competitive and general economic conditions, adverse effects of litigation, the timely development and acceptance of our products and services, significant changes in the competitive environment, the failure to generate or the loss of significant numbers of customers, the loss of senior management or increased government regulation.
Genmed Holding Corp.
Randy Hibma, 031 793 630 129